Avendus sees opportunities in banks, manufacturing and data centres; cautious on IT and real estate

Indian markets may remain on a stronger footing as corporate earnings improve across sectors, currency conditions stabilise and crude oil prices ease, according to S. Vijayaraghavan, Managing Director and Head of Research at Avendus Institutional Equities. Vijayaraghavan said investor sentiment has turned positive following strong earnings growth in the first two quarters of FY27. Companies…

Read More

UPL likely to revise February 2026 corporate restructuring plan soon: Exclusive

Agrochemical major UPL is likely to soon revise the corporate restructuring plan it originally announced in February 2026, sources told CNBC-TV18. During its recent second-quarter (Q2) earnings call, UPL management noted that market feedback regarding the reorganisation has been shared with the company’s board, adding that any material developments on the matter will be duly…

Read More

AI pricing reset may keep Indian IT growth weak for 2-3 years, CLSA prefers Coforge, Tech Mahindra

Indian IT companies may continue to face weak growth over the next two to three years as the sector remains in the middle of an AI-driven pricing reset, according to Sumeet Jain, Senior Research Analyst at CLSA. While artificial intelligence (AI) adoption is creating new opportunities, Jain said large-scale enterprise deployments are still some distance…

Read More

CLSA says AI infrastructure spending will stay high, chip shortage to remain key constraint

The recent correction in global AI-related stocks could present a buying opportunity as the artificial intelligence infrastructure cycle is far from over, according to Bhavtosh Vajpayee, International Head of Technology Research at CLSA. Speaking at the CITIC CLSA India Forum, Vajpayee said the AI build-out is expected to continue through the rest of the decade…

Read More

Caplin Point shares decline after USFDA issues OAI classification for Gummidipoondi facility

Caplin Point Laboratories Ltd. on Tuesday, November 17, said the US drug regulator has classified Caplin Steriles’ facility as ‘official action indicated’ (OAI). The company, in an exchange filing, said the US Food and Drug Administration (USFDA) inspected Caplin Steriles’ injectable and ophthalmic manufacturing facility in Gummidipoondi between August 13 and August 21, 2026. It…

Read More

Nvidia Q3 Results FY27: Earnings Estimates, Date, India Time and Key Expectations – Markets

Nvidia Q3 Results Preview: According to ET NOW Research estimates, Nvidia’s consolidated revenue is expected to rise 13.62 per cent quarter-on-quarter to $109.33 billion, compared with $96.22 billion in the previous quarter. Highlights Nvidia Q3 revenue, profit expected to rise sequentially. Investors await leadership updates following Jensen Huang’s exit. Nvidia’s EBIT margin is expected to…

Read More